CN109022299B - A kind of ERG1 gene defect Yeast engineering bacteria, its construction method and its utilization - Google Patents
A kind of ERG1 gene defect Yeast engineering bacteria, its construction method and its utilization Download PDFInfo
- Publication number
- CN109022299B CN109022299B CN201810896549.1A CN201810896549A CN109022299B CN 109022299 B CN109022299 B CN 109022299B CN 201810896549 A CN201810896549 A CN 201810896549A CN 109022299 B CN109022299 B CN 109022299B
- Authority
- CN
- China
- Prior art keywords
- erg1
- gene
- yeast
- leu
- squalene epoxidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 103
- 241000894006 Bacteria Species 0.000 title claims abstract description 77
- 101150093680 ERG1 gene Proteins 0.000 title claims abstract description 53
- 230000007547 defect Effects 0.000 title claims abstract description 31
- 238000010276 construction Methods 0.000 title abstract description 7
- 108020003891 Squalene monooxygenase Proteins 0.000 claims abstract description 36
- 108091033409 CRISPR Proteins 0.000 claims abstract description 21
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 94
- 108020004414 DNA Proteins 0.000 claims description 43
- 210000004027 cell Anatomy 0.000 claims description 36
- 108090000623 proteins and genes Proteins 0.000 claims description 35
- 101001047090 Homo sapiens Potassium voltage-gated channel subfamily H member 2 Proteins 0.000 claims description 31
- 235000015398 thunder god vine Nutrition 0.000 claims description 25
- 108020005004 Guide RNA Proteins 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 24
- 230000006870 function Effects 0.000 claims description 22
- 241000830536 Tripterygium wilfordii Species 0.000 claims description 20
- 102000005782 Squalene Monooxygenase Human genes 0.000 claims description 13
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 claims description 12
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 claims description 12
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 claims description 12
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 claims description 12
- 102100025560 Squalene monooxygenase Human genes 0.000 claims description 12
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 claims description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 241000235342 Saccharomycetes Species 0.000 claims description 9
- 239000013604 expression vector Substances 0.000 claims description 9
- 230000014509 gene expression Effects 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 102000053602 DNA Human genes 0.000 claims description 6
- 238000000137 annealing Methods 0.000 claims description 6
- 238000010367 cloning Methods 0.000 claims description 6
- 230000009466 transformation Effects 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 claims description 4
- 102000003960 Ligases Human genes 0.000 claims description 3
- 108090000364 Ligases Proteins 0.000 claims description 3
- 230000008827 biological function Effects 0.000 claims description 3
- 230000002950 deficient Effects 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 238000012795 verification Methods 0.000 claims description 3
- 210000005253 yeast cell Anatomy 0.000 claims 2
- 238000010354 CRISPR gene editing Methods 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000010362 genome editing Methods 0.000 abstract description 4
- 238000012217 deletion Methods 0.000 abstract description 2
- 230000037430 deletion Effects 0.000 abstract description 2
- 230000035772 mutation Effects 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 101100445499 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) erg-1 gene Proteins 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 37
- 239000000499 gel Substances 0.000 description 19
- 102100022807 Potassium voltage-gated channel subfamily H member 2 Human genes 0.000 description 18
- 239000002609 medium Substances 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 18
- 239000001963 growth medium Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 14
- 238000001179 sorption measurement Methods 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 13
- 238000012216 screening Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 101100008069 Rattus norvegicus Cuzd1 gene Proteins 0.000 description 9
- 101100517253 Rattus norvegicus Nsf gene Proteins 0.000 description 9
- 101150076597 SQLE gene Proteins 0.000 description 9
- 229930182558 Sterol Natural products 0.000 description 9
- 150000003432 sterols Chemical class 0.000 description 9
- 235000003702 sterols Nutrition 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 238000012258 culturing Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 229920000297 Rayon Polymers 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- PUERAZFQIXLYDR-CQNOQWDGSA-N 3-[(4e,8e,12e,16e)-4,8,13,17,21-pentamethyldocosa-4,8,12,16,20-pentaenylidene]oxetane Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C1COC1 PUERAZFQIXLYDR-CQNOQWDGSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000012148 binding buffer Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000003648 triterpenes Chemical class 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 3
- 229940025294 hemin Drugs 0.000 description 3
- 239000012160 loading buffer Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 2
- 241000219194 Arabidopsis Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- 108010045510 NADPH-Ferrihemoprotein Reductase Proteins 0.000 description 2
- 101150063416 add gene Proteins 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 229960000935 dehydrated alcohol Drugs 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000010583 slow cooling Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- HGRBNYQIMKTUNT-XVYDVKMFSA-N Ala-Asn-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HGRBNYQIMKTUNT-XVYDVKMFSA-N 0.000 description 1
- IYCZBJXFSZSHPN-DLOVCJGASA-N Ala-Cys-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IYCZBJXFSZSHPN-DLOVCJGASA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 1
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 1
- IETUUAHKCHOQHP-KZVJFYERSA-N Ala-Thr-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)N)[C@@H](C)O)C(O)=O IETUUAHKCHOQHP-KZVJFYERSA-N 0.000 description 1
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 1
- OTCJMMRQBVDQRK-DCAQKATOSA-N Arg-Asp-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OTCJMMRQBVDQRK-DCAQKATOSA-N 0.000 description 1
- NKNILFJYKKHBKE-WPRPVWTQSA-N Arg-Gly-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O NKNILFJYKKHBKE-WPRPVWTQSA-N 0.000 description 1
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 1
- GRRXPUAICOGISM-RWMBFGLXSA-N Arg-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GRRXPUAICOGISM-RWMBFGLXSA-N 0.000 description 1
- OMKZPCPZEFMBIT-SRVKXCTJSA-N Arg-Met-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OMKZPCPZEFMBIT-SRVKXCTJSA-N 0.000 description 1
- JQHASVQBAKRJKD-GUBZILKMSA-N Arg-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N JQHASVQBAKRJKD-GUBZILKMSA-N 0.000 description 1
- JPAWCMXVNZPJLO-IHRRRGAJSA-N Arg-Ser-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JPAWCMXVNZPJLO-IHRRRGAJSA-N 0.000 description 1
- WCZXPVPHUMYLMS-VEVYYDQMSA-N Arg-Thr-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O WCZXPVPHUMYLMS-VEVYYDQMSA-N 0.000 description 1
- ISVACHFCVRKIDG-SRVKXCTJSA-N Arg-Val-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O ISVACHFCVRKIDG-SRVKXCTJSA-N 0.000 description 1
- HLTLEIXYIJDFOY-ZLUOBGJFSA-N Asn-Cys-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O HLTLEIXYIJDFOY-ZLUOBGJFSA-N 0.000 description 1
- DDPXDCKYWDGZAL-BQBZGAKWSA-N Asn-Gly-Arg Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N DDPXDCKYWDGZAL-BQBZGAKWSA-N 0.000 description 1
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 1
- QXOPPIDJKPEKCW-GUBZILKMSA-N Asn-Pro-Arg Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O QXOPPIDJKPEKCW-GUBZILKMSA-N 0.000 description 1
- XLDMSQYOYXINSZ-QXEWZRGKSA-N Asn-Val-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N XLDMSQYOYXINSZ-QXEWZRGKSA-N 0.000 description 1
- VTYQAQFKMQTKQD-ACZMJKKPSA-N Asp-Ala-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O VTYQAQFKMQTKQD-ACZMJKKPSA-N 0.000 description 1
- PJERDVUTUDZPGX-ZKWXMUAHSA-N Asp-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(O)=O PJERDVUTUDZPGX-ZKWXMUAHSA-N 0.000 description 1
- NYQHSUGFEWDWPD-ACZMJKKPSA-N Asp-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)O)N NYQHSUGFEWDWPD-ACZMJKKPSA-N 0.000 description 1
- KHBLRHKVXICFMY-GUBZILKMSA-N Asp-Glu-Lys Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O KHBLRHKVXICFMY-GUBZILKMSA-N 0.000 description 1
- QPDUWAUSSWGJSB-NGZCFLSTSA-N Asp-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N QPDUWAUSSWGJSB-NGZCFLSTSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- VZKXOWRNJDEGLZ-WHFBIAKZSA-N Cys-Asp-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O VZKXOWRNJDEGLZ-WHFBIAKZSA-N 0.000 description 1
- CHRCKSPMGYDLIA-SRVKXCTJSA-N Cys-Phe-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O CHRCKSPMGYDLIA-SRVKXCTJSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 1
- QKWBEMCLYTYBNI-GVXVVHGQSA-N Gln-Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(N)=O QKWBEMCLYTYBNI-GVXVVHGQSA-N 0.000 description 1
- VCUNGPMMPNJSGS-JYJNAYRXSA-N Gln-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VCUNGPMMPNJSGS-JYJNAYRXSA-N 0.000 description 1
- FLQAKQOBSPFGKG-CIUDSAMLSA-N Glu-Cys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FLQAKQOBSPFGKG-CIUDSAMLSA-N 0.000 description 1
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 1
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 1
- BXSZPACYCMNKLS-AVGNSLFASA-N Glu-Ser-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BXSZPACYCMNKLS-AVGNSLFASA-N 0.000 description 1
- FIQQRCFQXGLOSZ-WDSKDSINSA-N Gly-Glu-Asp Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FIQQRCFQXGLOSZ-WDSKDSINSA-N 0.000 description 1
- SOEATRRYCIPEHA-BQBZGAKWSA-N Gly-Glu-Glu Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SOEATRRYCIPEHA-BQBZGAKWSA-N 0.000 description 1
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 1
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 1
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 1
- UWQDKRIZSROAKS-FJXKBIBVSA-N Gly-Met-Thr Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UWQDKRIZSROAKS-FJXKBIBVSA-N 0.000 description 1
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 1
- 101150074296 HEM1 gene Proteins 0.000 description 1
- 101150009006 HIS3 gene Proteins 0.000 description 1
- SGLXGEDPYJPGIQ-ACRUOGEOSA-N His-Phe-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N SGLXGEDPYJPGIQ-ACRUOGEOSA-N 0.000 description 1
- VCBWXASUBZIFLQ-IHRRRGAJSA-N His-Pro-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O VCBWXASUBZIFLQ-IHRRRGAJSA-N 0.000 description 1
- STGQSBKUYSPPIG-CIUDSAMLSA-N His-Ser-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 STGQSBKUYSPPIG-CIUDSAMLSA-N 0.000 description 1
- QLBXWYXMLHAREM-PYJNHQTQSA-N His-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CN=CN1)N QLBXWYXMLHAREM-PYJNHQTQSA-N 0.000 description 1
- NCSIQAFSIPHVAN-IUKAMOBKSA-N Ile-Asn-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N NCSIQAFSIPHVAN-IUKAMOBKSA-N 0.000 description 1
- LPXHYGGZJOCAFR-MNXVOIDGSA-N Ile-Glu-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N LPXHYGGZJOCAFR-MNXVOIDGSA-N 0.000 description 1
- CSQNHSGHAPRGPQ-YTFOTSKYSA-N Ile-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O)N CSQNHSGHAPRGPQ-YTFOTSKYSA-N 0.000 description 1
- NUKXXNFEUZGPRO-BJDJZHNGSA-N Ile-Leu-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)N NUKXXNFEUZGPRO-BJDJZHNGSA-N 0.000 description 1
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 1
- FHPZJWJWTWZKNA-LLLHUVSDSA-N Ile-Phe-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N FHPZJWJWTWZKNA-LLLHUVSDSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 101150068332 KIT gene Proteins 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N Leu-Ala-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 1
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 1
- NHHKSOGJYNQENP-SRVKXCTJSA-N Leu-Cys-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N NHHKSOGJYNQENP-SRVKXCTJSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- KVMULWOHPPMHHE-DCAQKATOSA-N Leu-Glu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KVMULWOHPPMHHE-DCAQKATOSA-N 0.000 description 1
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 1
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 1
- MUCIDQMDOYQYBR-IHRRRGAJSA-N Leu-Pro-His Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N MUCIDQMDOYQYBR-IHRRRGAJSA-N 0.000 description 1
- BTEMNFBEAAOGBR-BZSNNMDCSA-N Leu-Tyr-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BTEMNFBEAAOGBR-BZSNNMDCSA-N 0.000 description 1
- RDFIVFHPOSOXMW-ACRUOGEOSA-N Leu-Tyr-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RDFIVFHPOSOXMW-ACRUOGEOSA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- TUIOUEWKFFVNLH-DCAQKATOSA-N Leu-Val-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(O)=O TUIOUEWKFFVNLH-DCAQKATOSA-N 0.000 description 1
- VHXMZJGOKIMETG-CQDKDKBSSA-N Lys-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCCCN)N VHXMZJGOKIMETG-CQDKDKBSSA-N 0.000 description 1
- VHNOAIFVYUQOOY-XUXIUFHCSA-N Lys-Arg-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VHNOAIFVYUQOOY-XUXIUFHCSA-N 0.000 description 1
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 1
- QZONCCHVHCOBSK-YUMQZZPRSA-N Lys-Gly-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O QZONCCHVHCOBSK-YUMQZZPRSA-N 0.000 description 1
- MIMXMVDLMDMOJD-BZSNNMDCSA-N Lys-Tyr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O MIMXMVDLMDMOJD-BZSNNMDCSA-N 0.000 description 1
- QAHFGYLFLVGBNW-DCAQKATOSA-N Met-Ala-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN QAHFGYLFLVGBNW-DCAQKATOSA-N 0.000 description 1
- CTVJSFRHUOSCQQ-DCAQKATOSA-N Met-Arg-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CTVJSFRHUOSCQQ-DCAQKATOSA-N 0.000 description 1
- WNJXJJSGUXAIQU-UFYCRDLUSA-N Met-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 WNJXJJSGUXAIQU-UFYCRDLUSA-N 0.000 description 1
- MPCKIRSXNKACRF-GUBZILKMSA-N Met-Pro-Asn Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O MPCKIRSXNKACRF-GUBZILKMSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 108010047562 NGR peptide Proteins 0.000 description 1
- 101100123655 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) alv-1 gene Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- MIICYIIBVYQNKE-QEWYBTABSA-N Phe-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N MIICYIIBVYQNKE-QEWYBTABSA-N 0.000 description 1
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 1
- MGLBSROLWAWCKN-FCLVOEFKSA-N Phe-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MGLBSROLWAWCKN-FCLVOEFKSA-N 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 1
- LCRSGSIRKLXZMZ-BPNCWPANSA-N Pro-Ala-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LCRSGSIRKLXZMZ-BPNCWPANSA-N 0.000 description 1
- HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 1
- FKYKZHOKDOPHSA-DCAQKATOSA-N Pro-Leu-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FKYKZHOKDOPHSA-DCAQKATOSA-N 0.000 description 1
- WOIFYRZPIORBRY-AVGNSLFASA-N Pro-Lys-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O WOIFYRZPIORBRY-AVGNSLFASA-N 0.000 description 1
- RFWXYTJSVDUBBZ-DCAQKATOSA-N Pro-Pro-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RFWXYTJSVDUBBZ-DCAQKATOSA-N 0.000 description 1
- RCYUBVHMVUHEBM-RCWTZXSCSA-N Pro-Pro-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RCYUBVHMVUHEBM-RCWTZXSCSA-N 0.000 description 1
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
- 241000793189 Saccharomyces cerevisiae BY4741 Species 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- XSYJDGIDKRNWFX-SRVKXCTJSA-N Ser-Cys-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XSYJDGIDKRNWFX-SRVKXCTJSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 1
- QMCDMHWAKMUGJE-IHRRRGAJSA-N Ser-Phe-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O QMCDMHWAKMUGJE-IHRRRGAJSA-N 0.000 description 1
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 1
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 1
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 1
- TZKPNGDGUVREEB-FOHZUACHSA-N Thr-Asn-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O TZKPNGDGUVREEB-FOHZUACHSA-N 0.000 description 1
- KBLYJPQSNGTDIU-LOKLDPHHSA-N Thr-Glu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O KBLYJPQSNGTDIU-LOKLDPHHSA-N 0.000 description 1
- XPNSAQMEAVSQRD-FBCQKBJTSA-N Thr-Gly-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)NCC(O)=O XPNSAQMEAVSQRD-FBCQKBJTSA-N 0.000 description 1
- XYFISNXATOERFZ-OSUNSFLBSA-N Thr-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XYFISNXATOERFZ-OSUNSFLBSA-N 0.000 description 1
- ODXKUIGEPAGKKV-KATARQTJSA-N Thr-Leu-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)N)O ODXKUIGEPAGKKV-KATARQTJSA-N 0.000 description 1
- XSEPSRUDSPHMPX-KATARQTJSA-N Thr-Lys-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O XSEPSRUDSPHMPX-KATARQTJSA-N 0.000 description 1
- GUHLYMZJVXUIPO-RCWTZXSCSA-N Thr-Met-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O GUHLYMZJVXUIPO-RCWTZXSCSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 1
- TVOGEPLDNYTAHD-CQDKDKBSSA-N Tyr-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TVOGEPLDNYTAHD-CQDKDKBSSA-N 0.000 description 1
- HSVPZJLMPLMPOX-BPNCWPANSA-N Tyr-Arg-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O HSVPZJLMPLMPOX-BPNCWPANSA-N 0.000 description 1
- PRONOHBTMLNXCZ-BZSNNMDCSA-N Tyr-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PRONOHBTMLNXCZ-BZSNNMDCSA-N 0.000 description 1
- NSGZILIDHCIZAM-KKUMJFAQSA-N Tyr-Leu-Ser Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NSGZILIDHCIZAM-KKUMJFAQSA-N 0.000 description 1
- SOEGLGLDSUHWTI-STECZYCISA-N Tyr-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 SOEGLGLDSUHWTI-STECZYCISA-N 0.000 description 1
- BIWVVOHTKDLRMP-ULQDDVLXSA-N Tyr-Pro-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O BIWVVOHTKDLRMP-ULQDDVLXSA-N 0.000 description 1
- PWKMJDQXKCENMF-MEYUZBJRSA-N Tyr-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O PWKMJDQXKCENMF-MEYUZBJRSA-N 0.000 description 1
- JOQSQZFKFYJKKJ-GUBZILKMSA-N Val-Arg-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N JOQSQZFKFYJKKJ-GUBZILKMSA-N 0.000 description 1
- JIODCDXKCJRMEH-NHCYSSNCSA-N Val-Arg-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N JIODCDXKCJRMEH-NHCYSSNCSA-N 0.000 description 1
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 1
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 1
- WJVLTYSHNXRCLT-NHCYSSNCSA-N Val-His-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WJVLTYSHNXRCLT-NHCYSSNCSA-N 0.000 description 1
- VXDSPJJQUQDCKH-UKJIMTQDSA-N Val-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N VXDSPJJQUQDCKH-UKJIMTQDSA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 1
- LJSZPMSUYKKKCP-UBHSHLNASA-N Val-Phe-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 LJSZPMSUYKKKCP-UBHSHLNASA-N 0.000 description 1
- YQMILNREHKTFBS-IHRRRGAJSA-N Val-Phe-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N YQMILNREHKTFBS-IHRRRGAJSA-N 0.000 description 1
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 1
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 1
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010036533 arginylvaline Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 108010069495 cysteinyltyrosine Proteins 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000001921 nucleic acid quantification Methods 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 108010005652 splenotritin Proteins 0.000 description 1
- 108010088324 squalene cyclase Proteins 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/99—Miscellaneous (1.14.99)
- C12Y114/99007—Squalene monooxygenase (1.14.99.7)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to a kind of ERG1 gene defect Yeast engineering bacteria and its construction methods, the ERG1 gene defection type Yeast engineering bacteria is transformed yeast by CRISPR/Cas9 gene editing technology, realize the complete deletion of Erg1 gene order, it avoids yeast itself and repairs the back mutation phenomenon generated, obtaining one kind can be suitble to verify the engineering bacteria of other source squalene epoxidase enzymes genes.
Description
Technical field
The present invention relates to ERG1 genes in a kind of ERG1 gene defection type Yeast engineering bacteria and a kind of knockout saccharomycete
Method is transformed saccharomyces cerevisiae by CRISPR/Cas9 gene editing technology, by the squalene epoxidase in yeast chromosomal
Enzyme (Squalene epoxidase, ERG1) gene is knocked out, and the squalene ring for being suitble to the other sources of verifying is made
The defect bacterium of oxidase gene function, and the squalene ring cloned from tripterygium wilfordii is successfully authenticated by the yeast defect bacterium
Oxidase gene (Twse), belongs to genetic engineering field.
Background technique
The acquisition of Chinese medicine or the bioactive natural product in other sources depends on the extraction to original species, but this method
Acquired natural products is much unable to satisfy demand, is also easy to damage environment and resource.Pass through the structure in microorganism
The biosynthesis pathway of important secondary metabolites is built, realizes the production of natural products low cost, high yield, this will promote natural produce
The application of object and the research and development of new drug and the sustainable development of resource.The premise that this mode can be carried out is obtaining for genetic elements
It takes and the parsing of route of synthesis.
ERG1 is squalene epoxidase enzymes, because being the gene on endoplasmic reticulum Endoplasmic Reticulum,
It is named with Erg.Squalene epoxidase enzymes are the key genes on triterpene and sterol biosynthesis approach, its activity and function shadow
Ring the biosynthesis of triterpene and sterol.Squalene is in squalene epoxidase enzymes and its coenzyme cytochrome P450 reductase
Epoxy squalene (Fig. 1) is generated under the action of (Cytochrome P450 Reductase, CPR), epoxy squalene further converts
For triterpene or sterol substance.In plant, squalene epoxidase enzymes pass through the sterol and triterpene active component for influencing plant
Synthesis further influences the growth and development of plant and copes with biology and abiotic pressure.Research shows that being sent out in arabidopsis
Existing epoxy squalene enzyme SE1 gene affects the development of the root and seed of arabidopsis and SE3 gene influences the development of plumule and big
It is small.
Since squalene epoxidase enzymes belong to endoplasmic reticulum binding protein, function can be played by being difficult to give expression in Escherichia coli
Can squalene epoxidase enzymes, thus be difficult through prokaryotic expression, the method for external enzymatic verifies the shark of plant or other sources
The function of alkene Cycloxygenase.Yeast belongs to eucaryote, can be good at the squalene epoxidase enzymes for expressing plant or other sources,
But yeast itself also has squalene epoxidase enzymes gene, thus to the squalene epoxidase enzymes gene function of plant and other sources
Identification interferes.Early stage ERG1 gene in research yeast passes through the side of homologous recombination at the position on yeast chromosomal
Method is knocked out (bacterium is named as KLN1:MATa, ERG1::URA3, Ieu2, ura3, trp1) to the ERG1 gene in yeast.
Although yeast is facultative anaerobic bacteria, it require that oxygen is for synthesizing two class essential components: first is that sterol, another kind of is insatiable hunger
And fatty acid.Early period, people had found when studying yeast, and under aerobic conditions, yeast will not absorb etembonate in culture medium
Alcohol, and yeast can absorb ergosterol in culture medium in the absence of oxygen.Squalene epoxidase enzymes of the later period in verifying plant
Gene is typically all to be done by this bacterium of KLN1, this bacterium is right by the code area that selection markers are inserted into ERG1 gene
Building in yeast chromosomal is integrated by the method for homologous recombination afterwards, has the drawback that ERG1 gene does not strike completely
It removes, when verifying the function of external source se gene, there may be false positives.Also there are individual bacterium RXY6 (MATa using another transformation
erg7::HIS3 erg1::KanMX4 hem1::TRP1 ura3-52 trp1-△63 leu2–3,112 his3-△200
ade2 Gal+), the main advantage of this bacterium is that Hem1 has also been knocked out under the premise of having knocked out ERG1, and ferment can be made by knocking out Hem1
Mother absorbs ergosterol under conditions of aerobic in culture medium, but it is larger to knock out ERG1 and Hem1 difficulty simultaneously, and
Hem1 synthesizes particularly significant, the internal a variety of metabolic responses of hemin participation to hemin, therefore has knocked out the yeast of Hem1 gene
It needs to supplement hemin in culture medium.
The gene editing method that this research uses realizes the complete deletion of ERG1 gene order, avoids yeast itself and repairs
Raw back mutation phenomenon is reproduced, the engineering bacteria for being suitble to the other source squalene epoxidase enzymes genes of verifying is made.In addition, should
Plasmid used in method knockout process can be removed by high-temperature process, remain the selection markers of opportunistic pathogen strain, the scope of application
It is wider, and experimental implementation is simpler more quick than previous methods of homologous recombination.
Summary of the invention
One aspect of the present invention provides a kind of method for knocking out the ERG1 gene of itself in yeast, and the method is to pass through
CRISPR/Cas9 gene editing technology is transformed yeast, and the squalene epoxidase enzymes gene of itself, obtains one in knockout yeast
Kind can be suitble to verify the engineering bacteria of other source squalene epoxidase enzymes genes.It can construct in the following way and carry out gene
The verifying of function:
Website http://yeastriction.tnw.tudelft.nl/# is designed using yeast CRISPR/Cas9gRNA!/
The screening of the site gRNA is carried out to ERG1 gene, the site gRNA that screening obtains is building up in gRNA carrier, yeast is prepared
The gRNA carrier built and Cas9 carrier and homologous fragment are transferred to BY4741 yeast sense by BY4741 competent cell together
By state cell, 30 DEG C of anaerobic cultures in solid screening and culturing medium.PCR verifying and sequence verification are carried out to the single colonie grown.
Erg1 yeast defect bacterium 30 DEG C of anaerobic cultures in liquid screening medium that success constructs, preparation erg1 competent yeast are thin
Born of the same parents.
When being verified to the squalene epoxidase enzymes gene function in plant cell, such as the squalene in verifying tripterygium wilfordii
Cycloxygenase gene function can clone from thunder god vine suspending cell and obtain tripterygium wilfordii squalene epoxidase enzymes gene, by Twse
It is gene constructed into pESC-his carrier for expression of eukaryon, be transformed into erg1 yeast defect bacterium, verified by way of having complementary functions
Twse gene function.
Specifically, the method for knocking out the ERG1 gene of itself in yeast, comprising:
(1) site gRNA of ERG1 gene is screened;
(2) building knocks out the expression vector of ERG1 gene;
(3) Cas9 carrier is transformed, the selection markers TRP of p414-TEF1p-Cas9-CYC1t is replaced with into LEU;
(4) double-stranded DNA (dsOligo) of ERG1 gene is obtained
(5) yeast Competent cell is prepared;
(6) by the gRNA carrier containing yeast ERG1 gene specific recognition site, the Cas9 carrier being transformed and conjunction
At ERG1 double-stranded DNA convert in the competent cell into rapid (5), the anaerobic culture on screening and culturing medium SC-Leu-Ura,
Obtain the saccharomycete for being mutated successful ERG1 gene defect.
One more specifically scheme be:
(1) site gRNA of ERG1 gene, the gene order in the site gRNA are screened are as follows:
TATCTTTTCACGTTTCAGAA;
(2) it using EGR1-F and EGR1-R as primer, is cloned using p426-SNR52p-gRNA carrier for expression of eukaryon as template
Blunt end cloning is carried out to linear carrier, and with T4 ligase, building obtains knocking out the gRNA expression vector of ERG1 gene,
The primer sequence are as follows:
ERG1-F:TATCTTTTCACGTTTCAGAAGTTTTAGAGCTAGAA,
ERG1-R:GATCATTTATCTTTCACTGCGGAGAAG;
(3) Cas9 carrier is transformed, the selection markers TRP of p414-TEF1p-Cas9-CYC1t is replaced with into LEU;
(4) design knocks out the dsOligo of ERG1 gene, is knocked out by homologous recombination repair to target gene, institute
The sequence of ERG1-Oligo-F and ERG1-Oligo-R are as follows:
ERG1-Oligo-F:
CAGGTTATTTCGAACAATTGAAAAAAAAAAATCACAGAAAAACATATCGAGAAAAGGGTCCTACAGCT
TATAAGGGAGAGAGGATAGGAACCGTCAAACATTAAGCTGCACCTTTTTTTT,
ERG1-Oligo-R:
AAAAAAAAGGTGCAGCTTAATGTTTGACGGTTCCTATCCTCTCTCCCTTATAAGCTGTAGGACCCTTT
TCTCGATATGTTTTTCTGTGATTTTTTTTTTTCAATTGTTCGAAATAACCTG,
The dsOligo of the ERG1 gene is obtained by annealing ERG1-Oligo-F and ROX1-Oligo-R to form DNA
Double-strand, and recovery purifying both obtains;
(5) according to Frozen-EZ Yeast Transformation IITMKit specification prepares yeast chemoreception
State cell;
(6) by the gRNA carrier containing yeast ERG1 gene specific recognition site, the Cas9 carrier being transformed and conjunction
At ERG1 double-stranded DNA convert in the competent cell into rapid (5), the anaerobic culture on screening and culturing medium SC-Leu-Ura,
Obtain the saccharomycete for being mutated successful ERG1 gene defect.
PCR verifying and sequence verification are carried out to the saccharomycete of ERG1 gene defect, to confirm that obtain is correct gene
Defective yeast.Erg1 yeast defect bacterium 30 DEG C of anaerobic cultures in liquid screening medium that success constructs prepare erg1 ferment
Female competent cell.
The squalene epoxidase enzymes gene in the plant to be verified is cloned, then by gene constructed into carrier for expression of eukaryon,
It is transformed into erg1 yeast defect bacterium again, squalene epoxidase enzymes gene function is verified by way of having complementary functions.
In the present invention, the Yeast engineering bacteria can be selected from GEN.PK system S. cervisiae or BY system S. cervisiae,
Preferably BY system saccharomyces cerevisiae, such as BY4741 saccharomyces cerevisiae.
A further object of the present invention is to provide a kind of ERG1 gene defection type Yeast engineering bacteria, the yeast can be selected
From GEN.PK system S. cervisiae or BY system S. cervisiae, preferably BY system saccharomyces cerevisiae, such as BY4741 saccharomyces cerevisiae.
In one more particular embodiment, the present invention provides a kind of BY4741 yeast engineerings of ERG1 gene defection type
Bacterium, the gene defection type Yeast engineering bacteria can be used for verifying the squalene epoxidase enzymes gene function in plant cell, be such as used for
Verify tripterygium wilfordii squalene epoxidase enzymes gene (Twse) function.
ERG1 gene defection type Yeast engineering bacteria of the present invention can such as ERG1 deficiency BY4741 Yeast engineering bacteria
To construct to obtain by the above method.
A further object of the present invention is to provide ERG1 gene defection type Yeast engineering bacterias of the present invention, such as ERG1 gene
Deficiency BY4741 saccharomycete, the utilization in verifying squalene epoxidase enzymes gene function, as verified squalene ring in plant cell
Oxidase gene function demonstrates squalene epoxidase enzymes gene function in plant tripterygium wilfordii in a more specifically embodiment.
Another object of the present invention is to provide squalene epoxidase enzymes gene in a kind of verifying plant cell (such as tripterygium wilfordii)
The method of function, which comprises respectively by expression vector (such as pESC-his- containing plant squalene epoxidase enzymes gene
Twse carrier) and accordingly the empty carrier (pESC-his empty carrier) without plant squalene epoxidase enzymes gene is transformed into ERG1 gene
In defective yeast engineering bacteria (such as ERG1 gene defection type BY4741 saccharomycete) competent cell, then in screening and culturing medium
On, it is cultivated under 30 DEG C aerobic and oxygen free condition, if being transferred to the erg1 yeast defect of the genophore containing squalene epoxidase enzymes
Bacterium can grow under aerobic and oxygen free condition, and confirmation has biological function, and the screening and culturing medium is that SC-his adds ergot
Sterol culture medium.
Detailed description of the invention
Fig. 1 squalene is cyclized enzymatic response diagram.
Fig. 2 Erg1 knocks out schematic diagram and gel electrophoresis figure.
Fig. 3 Erg1 yeast defect bacterium proof diagram, wherein 1 is erg1 defect yeast growth situation under aerobic conditions, 2 be anaerobic
Under the conditions of Erg1 defect yeast growth situation.
Fig. 4 tripterygium wilfordii Total RNAs extraction result figure.
Fig. 5 tripterygium wilfordii Twse gene gel electrophoresis figure.
Fig. 6 tripterygium wilfordii Twse functional complementation figure, wherein 1 and 2 be respectively inhomogeneity under oxygen free condition and aerobic conditions
Type erg1 Yeast Growth situation, 1 (a) and 2 (a) is the erg1 yeast defect bacterium for not being transferred to any carrier, and 1 (b) and 2 (b) is
It is transferred to the erg1 yeast defect bacterium of empty carrier pESC-his, 1 (c) and 2 (c) is to be transferred to the erg1 yeast of pESC-his-Twse to lack
Fall into bacterium.
Specific embodiment
Experimental method used in following embodiments is conventional method unless otherwise specified.
The materials, reagents and the like used in the following examples is commercially available unless otherwise specified.
High fidelity enzymeHigh-Fidelity DNA Polymerase, restriction enzyme and T4 ligase are equal
From (NEB company), Trans-T1 competent escherichia coli cell, EasyTaq DNA Polymerase, pEASY-Blunt
Zero Cloning Kit, seamless spliced kit UniSeamLess Cloning and Assembly Kit (the full formula in Beijing
Golden Bioisystech Co., Ltd), AraI restriction endonuclease and Ago-Gel DNA QIAquick Gel Extraction Kit Gene JET Gel
Extraction Kit (Thermo Scientific company, the U.S.), the small extraction reagent kit of rapid plasmid (Beijing Tiangeng biochemical technology
Co., Ltd), Annealing Buffer (Origene company, the U.S.), T4DNA Ligase (HC) andSuper is total
RNA extracts kit (Promega (Beijing) Bioisystech Co., Ltd), SC-His yeast culture medium and SC-Ura-Leu yeast
Culture medium (the general Jino Science and Technology Ltd. in Beijing), the yeast culture medium laboratory saccharomyces cerevisiae BY4741 save, p426-
SNR52p-gRNA carrier for expression of eukaryon and p414-TEF1p-Cas9-CYC1t carrier for expression of eukaryon are purchased from Addgene, and primer closes
It is completed at sequencing by Beijing Rui Bo company.
The building of embodiment 1, Erg1 yeast defect bacterium
One, website http is designed using yeast CRISPR/Cas9gRNA: //
yeastriction.tnw.tudelft.nl/#!/ screening of the site gRNA is carried out to ERG1 gene, ERG1 gene gRNA sequence is such as
Following table.
1 ERG1 gene gRNA sequence of table
Two, gRNA vector construction
GRNA sequence is added to gRNA skeleton front end by the method for design of primers, the method for using RF to clone is with p426-
SNR52p-gRNA carrier for expression of eukaryon (purchase of the official website Addgene) is that template clones to obtain linear carrier sequence, and is connected by T4
It connects enzyme and carries out blunt end cloning, the gRNA carrier in the site of the gene specific of ERG1 containing yeast identification can be obtained.Primer information
It is as follows:
2 gRNA vector construction primer of table
1, RF is cloned
System:
Reaction condition:
* Tm value is the annealing temperature of primer, and extension of time is set according to the length of primer
2, linear carrier purifies
Above-mentioned PCR product is taken out, respectively takes 5uL to add 6 × Loading Buffer of 2 μ L, is compareed with 8k Marker,
Run 1.0% Ago-Gel (180V, 10min).After seeing purpose amplified band, the DMT of 1uL is added in resultant product
Enzyme mixes, and digests at 37 DEG C one hour (purpose is removal template plasmid DNA, to reduce false positive).It will be in reacted product
Be added 10uL 6 × Loading Buffer, compareed with 8k Marker, run 1.5% Ago-Gel (120V,
30min).Under ultraviolet bale cutting instrument, purpose band is cut, recycles segment with Ago-Gel DNA QIAquick Gel Extraction Kit, step is such as
Under:
(1) equimultiple volume solution B inding Buffer is added into blob of viscose, and (if gel weight is 0.1g, volume is visual
For 100 μ L, then 100 μ L Binding Buffer solution are added), 55 DEG C of water-baths are placed, constantly leniently spin upside down therebetween from
Heart pipe, to ensure that blob of viscose sufficiently dissolves.If can continue to place a few minutes or add some colloidal sols again there are also not molten blob of viscose
Liquid, until blob of viscose is completely dissolved and (if the volume of blob of viscose is excessive, blob of viscose can be cut into fragment in advance).
(2) glue being completely dissolved being added in adsorption column (adsorption column is put into collecting pipe), 12000rpm is centrifuged 60s,
The waste liquid in collecting pipe is outwelled, adsorption column is put into collecting pipe.
(4) 700 μ l rinsing liquid Wash Buffer are added into adsorption column and (anhydrous second have been added using preceding first check whether
Alcohol), 12000rpm is centrifuged 60s, outwells the waste liquid in collecting pipe, adsorption column is put into collecting pipe.
(5) 12000rpm void column is centrifuged 1min, eliminates rinsing liquid as far as possible.Adsorption column is placed in new 1.5mL centrifuge tube,
Wave alcohol.
(6) sterile water of 20 μ l preheating is added into adsorption column filter membrane, is placed at room temperature for 1min.12000rpm is centrifuged 1min and receives
Set dna solution.
3, carrier connects
The carrier segments concentration obtained using NanoDrop measurement recycling, prepares coupled reaction system according to following ratio:
Condition: 25 DEG C of 2h
4, connection product converts
(1) above-mentioned connection product is all added in the DMT competent cell of 100 μ L, 30min is placed in ice;
After (2) 42 DEG C of heat shock 1min, then place 2min in ice;
(3) the addition not antibiotic LB culture medium of 1mL, 30 DEG C, 180rpm shaken cultivation 1h;
(4) it draws 200 μ L bacterium solutions to be coated on LB+Amp film solid media, 30 DEG C of * cultivate 14h, observe bacterium colony growing state.
* the plasmid is temperature-sensitive plasmid, therefore is cultivated using 30 DEG C of low temperature its host strain.
5, bacterium solution PCR verifies positive bacterium colony
In super-clean bench, with the single bacterium colony in the sterilized white pipette tips picking plate of 10 μ L, it is placed in LB+Amp culture medium
In, 30 DEG C, after 250rpm constant-temperature shaking culture about 1-2h, 1 μ L bacterium solution is taken to carry out bacterium solution PCR, testing goal segment whether with load
On body effectively connects.
PCR reaction system:
PCR reaction condition:
PCR product is observed in gel imager after the detection of 1% agarose gel electrophoresis.700bp or so mesh to occur
The bacterium solution of segment band send sequencing company to be sequenced;The bacterial strain of the sequencing result positive is chosen, the glycerol for being added 20% is stored in -80
In DEG C refrigerator, and it is stand-by to draw LB+Amp plate.
Three, Cas9 vector modification
Since the selection markers TRP of p414-TEF1p-Cas9-CYC1t carrier is not suitable for BY4741 yeast, this reality
Test it is middle TRP selection markers are replaced with into LEU by the way of seamless spliced, LEU sequence template deposits pESC-LEU by laboratory
Plasmid.
3 Cas9 vector modification primer of table
(1) it is as template amplification LEU sequence, with p414-TEF1p-Cas9-CYC1t plasmid using pESC-LEU plasmid respectively
Template amplification TRP upstream sequence, downstream sequence, primer are LEU-F/R, U-F/R, D-F/R respectively.
(2) p414-TEF1p-Cas9-CYC1t plasmid double digestion
The DraIII of the SnaBI restriction endonuclease sites and downstream 323bp of choosing TRP1 ORF upstream 148bp is restricted
Restriction enzyme site.
Condition: 37 DEG C of 2h
(3) each segment of gel extraction, operation are same as above.
(4) In-Fusion reacts
Note: n (carrier): n (segment)=1:2
Condition: 50 DEG C of incubation 15min;It places on ice.
(5) 10 μ L splicing products are transformed into 50 μ L Trans1-T1 competent cells, it is solid to apply LB+Amp for 30 DEG C of recoveries
Body culture medium, 30 DEG C of overnight incubations.
(6) picking single colonie, 30 DEG C of LB+Amp fluid nutrient medium, 250rpm shakes 4~6h of training, and bacterium solution PCR verifying, primer is such as
Under, if PCR product the band near 1740bp occurs through agarose gel electrophoresis detection, send company to be sequenced corresponding bacterium solution.
8 Cas9 vector modification bacterium solution PCR primer of table
(7) correct bacterium solution will be sequenced and shake training, extract plasmid, and by the glycerol of addition 20% in bacterium solution, -80 DEG C are frozen.
Four, the acquisition of dsOligo
In order to obtain the mutant strain of specific genotype, double-stranded DNA (dsOligo) is needed to mediate homologous recombination repair.?
In saccharomyces cerevisiae, homologous arm lengths can be obtained 80% or more the homologous recombination efficiency obtained when being 60bp, takes and deletes in this experiment
Except the mode of whole gene achievees the purpose that gene knockout, i.e., the homology arm of 60bp is respectively designed (altogether in gene ORF upstream and downstream
120bp) target gene is knocked out by homologous recombination repair.The dsOligo of ERG1 gene is using the 120nt long-chain synthesized
Oligo anneals to form DNA double chain, and recovery purifying obtains.
Oligo anneals to form double-strand:
(1) by one pipe of 4OD oligo synthesis, ddH is used2O is diluted to 10pmol/ μ L, oligo sequence such as following table.
Table 3-9 dsOligo sequence
Condition: 95 DEG C of 5min
95~25 DEG C -1 DEG C/min 71cycles
10℃ hold
(2) dsOligo is purified
By annealed product according to Gene JET Gel Extraction Kit plastic recovery kit recovery purifying, step is such as
Under:
1. according to volume ratio annealing system: isopropanol: the amount mixing of Binding Buffer=1:1:1;
2. mixed liquor is transferred in Gene JET gene recovery purifying column, 12000rpm is centrifuged 1min, discards efflux,
Then column is put back into identical collecting pipe;
3. 700 μ LWash Buffer (being diluted with ethyl alcohol) are added to Gene JET purification column.12000rpm centrifugation
1min discards efflux, and column is then put back to identical collecting pipe;
4. being centrifuged sky GeneJET purification column 12000rpm is centrifuged 1min, remaining Wash Buffer is completely removed;
5. Gene JET purification column is transferred to a clean 1.5mL centrifuge tube, add 20 μ L ddH2O (can 60 DEG C it is pre-
Heat) in purification column film, 12000rpm is centrifuged 1min, abandons purification column, centrifugation gained liquid is the purpose dsOligo purified.
(3) concentration is surveyed, is tested for subsequent yeast conversion.
Five, prepared by BY4741 Competent cell
According to Frozen-EZ Yeast Transformation IITMKit specification carries out yeast Competent
The preparation of cell, steps are as follows:
(1) BY4741 bacterium solution is drawn into YPD solid culture plate, picking single bacterium falls within 10mL YPD fluid nutrient medium after 48h
In 30 DEG C, 220rpm is incubated overnight, until OD600=0.8-1.0.
(2) 500 × g are centrifuged 4min and precipitate thallus, abandon supernatant;
(3) 10mL EZ1 resuspension, washing thalline, 500 × g are centrifuged 4min, abandon supernatant;
(4) thallus is resuspended in 1mL EZ2, and every 50 μ L packing, one pipe is spare.
Note: the competent cell prepared can be converted directly or slow cooling freeze to -80 DEG C (4 DEG C, 1h;- 20 DEG C,
1h;-80℃).
Six, the conversion of Cas9 carrier, gRNA carrier and homologous fragment
(1) 1 μ g of 0.2-1 μ g (≤5 μ L) Cas9 plasmid pZJW01, gRNA about 500ng, Erg1dsOligo is taken, according to not
Mixed system is made into knockout purpose to be added in 100 μ L BY4741 competent cells;
(2) 500 μ L EZ3 solution are added, thoroughly mix;
(3) 30 DEG C of incubation 45min, rock 2-3 times in the process;
(4) it takes 200 μ L of bacterium solution to be coated on screening and culturing medium SC-Leu-Ura and adds ergosterol (20ug/mL) solid medium
On, 30 DEG C of 48~72h of anaerobic culture.
(5) single colonie that picking is grown is cultivated in YPD plus ergosterol (20ug/mL) fluid nutrient medium, until culture medium
Muddiness, the bacterial strain not to be transformed carry out PCR with following primer pair bacterium solution, whether testing goal gene mutates as control.
11 abrupt climatic change primer of table
Agarose gel electrophoresis detection, send company to be sequenced positive PCR product, and it is to be mutated successfully that correct bacterial strain, which is sequenced,
Bacterial strain.Gel electrophoresis and sequencing result are shown, successfully by the ERG1 gene knockout in yeast BY4741 (see Fig. 2).
(6) successful erg1 defect saccharomycete will be sequenced and expand 5mL culture by one thousandth, in 30 DEG C of anaerobic culture conditions
Under (YPD adds ergosterol (20ug/mL) fluid nutrient medium) culture to muddiness.Bacterium solution is taken to add ergosterol solid culture in YPD
Plank is drawn on base, respectively at aerobic or 30 DEG C of oxygen free condition cultures, further verifies whether ERG1 gene knocks out completely.
Since the biosynthesis of sterol in ERG1 gene pairs yeast plays an important role, the ferment of ERG1 gene is knocked out
Mother can not survive in the case where lacking sterol.In addition, there is exclusiveness to exogenous sterol since yeast is under aerobic conditions,
Therefore, under aerobic conditions, it can not be absorbed and utilized and grow ergosterol is added even if in culture medium.This experimental result is aobvious
Show, knocks out the yeast defect bacterium of ERG1 gene under conditions of aerobic, even if ergosterol is added in culture medium, can not also grow
(see Fig. 3).The results show, erg1 yeast defect bacterium construct successfully.
Embodiment 2, tripterygium wilfordii epoxy squalene cyclase gene full-length clone
One, thunder god vine suspending cell Total RNAs extraction
1, the culture and induction of thunder god vine suspending cell
(1) MS culture (containing hormone) is prepared: 4.43gL-1MS, 0.5mg.L-12,4-D, 0.1mgL-1KT,
0.5mg.L-1IBA, 30gL-1Sucrose adjusts pH=5.8.Then 121 DEG C, high steam pot sterilizing 20min.
(2) elicitor methyl jasmonate (MeJA) solution is prepared: 115 μ L 95%MeJA being dissolved in 885 μ L DMSO, are matched
0.5M MeJA mother liquor is made.MeJA used in preparation and DMSO uses 0.22 μm of filtering with microporous membrane, and in gnotobasis
Mixing.
(3) about 2g suspension cell, is aseptically inoculated in by the thunder god vine suspending cell for taking MS Liquid Culture to save
Squamous subculture is carried out in 100mL triangular flask equipped with 25mL MS fluid nutrient medium, is used as test material after culture to 10d.Culture
Condition is 25 ± 1 DEG C, 120rpm, and suspend culture under dark condition.
(4) MeJA is handled: being separately added into final concentration of 50 μ of MeJA into the thunder god vine suspending cell culture medium of culture 10d
mol·L-1Induction processing is carried out, same amount of solvent DMSO is added in control group.12,24 and 48h after treatment filters receipts respectively
Suspension cell is obtained, 3 biology of each time point repeat, and -80 DEG C of preservations (are extracted total after liquid nitrogen flash freezer after being blotted with filter paper
RNA)。
2、Super total RNA extraction reagent box extracts thunder god vine suspending cell:
(1) it takes about 50mg suspension cell in 2mL EP, is crushed under liquid nitrogen environment.
(2) 500 μ L RNA lysates are added in the sample crushed, overturn centrifuge tube 3~4 times, mixes.
(3) 500 μ L dilutions are added, liquid-transfering gun mixes, and 14000rpm is centrifuged 5min.
(4) dehydrated alcohol of 0.5 times of volume is added in the supernatant after being centrifuged, mixes.
(5) mixed liquor is transferred in centrifugal column, 12000~14000rpm is centrifuged 1min, abandons filtrate.
(6) 600 μ L washing lotions are added into centrifugal column, 12000~14000rpm is centrifuged 45s, abandons filtrate.
(7) 50 μ L DNA enzymatic I are added, are incubated for 15min.
μ L RNase-free water stands two minutes, and 12000~14000rpm is centrifuged 1min, collects RNA, -70 DEG C of preservations.
(RNA mentions Total RNA
(8) 600 μ L washing lotions are added into centrifugal column, 12000~14000rpm is centrifuged 45s, abandons filtrate.It is repeated once.
(9) void column is centrifuged 2min.
(10) into centrifugal column be added 50~200 μ L RNase-free water, stand two minutes, 12000~14000rpm from
Heart 1min collects RNA, -70 DEG C of preservations.(RNA extracts result and sees Fig. 4)
Two, reversion obtains the first chain cDNA
(1) genomic DNA is removed
42 DEG C, 3min.
(2) the first chain cDNA is inverted
42 DEG C, 15min;95 DEG C, 3min.
Three, Twse full length gene is cloned
According to transcript profile data, tripterygium wilfordii squalene epoxidase enzymes gene specific primer is designed:
3 Twse full-length clone primer of table
Full-length clone PCR reaction system:
* template DNA is the tripterygium wilfordii cDNA inverted in above-mentioned embodiment 2
Overall length PCR response procedures:
* Tm value is the annealing temperature of primer, and extension of time is set according to the length of primer
The 2k plus Marker of 6 × Loading Buffer (Tiangeng) that PCR product takes 5 μ L to add 2 μ L, 5 μ L are compareed,
Run 1% Ago-Gel (180V, 10min), test strip size (Fig. 5).
After confirming stripe size, resultant product respectively adds the 2k plus Marker of the 6xLoading Buffer, 10 μ L of 9 μ L
It compares, runs 1.5% Ago-Gel (120V, 30min).
Under ultraviolet bale cutting instrument, purpose band is cut, recycles segment with Ago-Gel DNA QIAquick Gel Extraction Kit:
(1) gel containing DNA fragmentation is cut with scalpel or slasher, is cut as far as possible close to DNA fragmentation, by glue
Piece is placed on the 1.5mL centrifuge tube weighed in advance and weighs.The weight of recording film.
(2) plus the Binding Buffer of 1:1 amount (is measured by weight, such as every 100mg Ago-Gel adds into film
The Binding Buffer of 100 μ L);
(3) gel mixture 10min is incubated under conditions of 50-60 DEG C, is during which mixed by inversion 2-3 times, and glue is promoted to melt,
Guarantee that glue all dissolves;
(4) most 800 μ L gel lysates are shifted to gene recovery purifying column, 12000rpm is centrifuged 1min, discards outflow
Then column is put back to identical collecting pipe by liquid;
(5) 700 μ L Wash Buffer (being diluted with ethyl alcohol) are added and arrive Gene JET purification column.12000rpm centrifugation
1min discards efflux, and column is then put back to identical collecting pipe;
(6) centrifugation sky GeneJET purification column 12000rpm is centrifuged 1min, completely removes remaining Wash Buffer;
(7) Gene JET purification column is transferred to a clean 1.5mL centrifuge tube, adds 30-50 μ L ddH2O (can be 60 DEG C
Preheating) in purification column film, 12000rpm is centrifuged 1min;
(8) it loses Gene JET purification column and stores the DNA of purifying at -20 DEG C.
Four, carrier T connection, competence conversion and positive colony PCR identification
It is real using pEASY-T3Cloning Vector or pEASY-Blunt Vector (Beijing Quan Shijin biotech firm)
Universal primer (M13Forward Primer:5 '-GTAAAACGACGGCCAGT-3 ' is synthesized before testing;M13Reverse Primer:
5'-CAGGAAACAGCTATGAC-3');Or positive colony PCR identification is carried out using segment special primer.
(1) pEASY-T3Cloning Vector or pEASY Blunt Vector operation instructions are referred to, T is carried out and carries company
It connects;
(2) whole T load connection product (5 μ L) is added in the DH5 α competent cell of 50 μ L, 30min is placed in ice;
(3) 42 DEG C of heating 60-90s, then place 2min in ice;
(4) the LB culture medium of 500 μ L is added, is placed in shaking table and cultivates 45-60min, condition of culture is 37 DEG C, 180rpm;
(5) after taking out, in super-clean bench, bacterium solution is spread evenly across on LB+AMP plate with spreader to (AMP is final concentration of
100mg·L-1, subsequent LB+AMP used concentration thus), after bacterium solution absorbs completely, culture is inverted in 37 DEG C of insulating boxs
12-16h;
(6) after bacterium colony is grown, the picking monoclonal colonies in super-clean bench are gone to containing 1mL LB+AMP fluid nutrient medium
EP pipe in;
(7) 3-6h is cultivated on shaking table, condition of culture is 37 DEG C, 250rpm;
(8) take 1 μ L bacterium solution as pcr template, whether testing goal segment connects carrier;
PCR reaction system:
PCR reaction condition:
(9) agarose gel electrophoresis detects PCR product, the bacterium solution of target fragment band will occurs, sequencing company is sent to be sequenced.
Five, escherichia coli plasmid extracts
(1) it takes positive colony and correct bacterium solution is sequenced, be transferred to the training of 20mL LB+AMP liquid in millesimal ratio
It supports in base, 12-16h is cultivated on shaking table, condition of culture is 37 DEG C, 250rpm;
(2) plasmid in bacterium solution is extracted using Plasmid Mini Kit kit (OMEGA), knows the details step reference
Book;
(3) plasmid concentration is measured with nucleic acid quantification instrument, deposits in -20 DEG C.
Five, construction of eukaryotic expression vector
(1) Twse gene open reading frame (ORF) expands:
3 Twse ORF cloning primer of table
PCR system, reaction condition and DNA fragmentation recycling step are same as above.
(2) pESC-his carrier double digestion
Double enzyme digestion reaction system:
* DNA is pESC-his carrier, and restriction endonuclease is each 1 μ L of NotI and PacI.
Condition: 37 DEG C, 2h.
Digestion products add the 2k plus Marker of the 6xloading Buffer, 10 μ L of 9 μ L to compare, and run 1.5%
Ago-Gel (120V, 30min).Under ultraviolet bale cutting instrument, purpose band is cut, with Ago-Gel DNA reclaim reagent
Box recycling segment step is same as above.
(3) carrier and segment are seamless spliced
Linked system:
* in 10 μ L reaction systems, carrier and each Insert Fragment additional amount are in 0.01-0.25pmols, carrier and each segment
Optimum mole ratio be 1:2.Pmols=mass ng/ (fragment length bp × 0.65kDa)
Condition: 50 DEG C, 15min.
Five, it converts, verifying, upgrading grain
(1) it takes above-mentioned linked system to be added in the Trans1-T1 competent cell of 50 μ L, 30min is placed in ice;
After (2) 42 DEG C of heat shock 1min, then places and stand 2min in ice;
(3) the LB culture mediums without Amp of 42 DEG C of 500 μ L preheatings of addition, 37 DEG C, 180rpm shaken cultivation 60min;
(4) about 200 μ L bacterium solutions are drawn to be coated on LB+Amp culture plate, culture 12- is inverted under 37 DEG C of dark conditions
16h;
(5) operate in super-clean bench of the picking single colonie process after ultraviolet disinfection: the single colonie in picking plate is placed in
In LB+Amp fluid nutrient medium, 37 DEG C, after 250rpm constant-temperature shaking culture about 1-2h, 1 μ L bacterium solution is taken to carry out PCR, testing goal
Whether segment effectively connect with carrier.
PCR reaction system:
PCR reaction condition:
(remarks: * indicates segment > 3kb of PCR product, and often adds 1kb then extension of time extension 1min)
Product is observed in gel imager after the detection of 1% agarose gel electrophoresis.Target fragment band to occur
Bacterium solution send company to be sequenced;
(6) according to sequencing result, the correct bacterium solution of sequencing result is chosen in millesimal ratio and expands culture,
250rpm, 37 DEG C of culture 10-12h.
(7) bacterium solution for taking 1-4mL to be incubated overnight is added in centrifuge tube, and 12,000rpm (~13,400 × g) are centrifuged 1min,
Absorb supernatant (bacterial sediment can be collected into a centrifuge tube by being repeatedly centrifuged when bacterium solution is more) as far as possible.
(8) be added in the centrifuge tube of Xiang Liuyou bacterial sediment 150 μ L solution P1 (check whether be added RNase A and
TIANRed), precipitated using pipettor or the thorough suspended bacterial of turbula shaker.
(9) 150 μ L solution P2 are added into centrifuge tube, leniently spinning upside down 6-8 times cracks thallus sufficiently.
(10) 350 μ L solution P5 are added into centrifuge tube, rapidly turns upside down mix 12-20 times immediately, mix well,
To occur flocculent deposit at this time.12,000rpm(~13,400 × g) centrifugation 2min.
(11) supernatant that previous step is collected is transferred in adsorption column CP3 with pipettor to (adsorption column is put into collecting pipe
In), pay attention to trying not that precipitating is sucked out.12,000rpm (~13,400 × g) are centrifuged 30sec, outwell the waste liquid in collecting pipe,
Adsorption column CP3 is put into collecting pipe.
(12) it is added 300 μ L rinsing liquid PWT (dehydrated alcohol has been added) into adsorption column CP3,12,000rpm (~13,
400 × g) centrifugation 30sec, outwells the waste liquid in collecting pipe, adsorption column CP3 is put into collecting pipe.
(13) adsorption column CP3 is put into collecting pipe, 12,000rpm (~13,400 × g) are centrifuged 1min.
(14) adsorption column CP3 is placed in a clean centrifuge tube, it is sterile that 30 μ L are added dropwise to the intermediate position of adsorbed film
Plasmid solution is collected into centrifuge tube by water, 12,000rpm (~13,400 × g) centrifugation 1min.Three pipes unification pipe, -20 DEG C of guarantors
It deposits.
Embodiment 3, the verifying of tripterygium wilfordii squalene epoxidase enzymes gene function
One, prepared by Erg1 defect competent yeast
According to Frozen-EZ Yeast Transformation IITMKit specification carries out yeast Competent
The preparation of cell, steps are as follows:
(1) picking constructs successful erg1 single colonie, in 30 DEG C of oxygen free conditions of 20mL YPD+ ergosterol (20ug/mL)
It is lower to cultivate to OD600=0.8-1.0.
(2) 500 × g are centrifuged 4min and precipitate thallus, abandon supernatant;
(3) 10mL EZ1 resuspension, washing thalline, 500 × g are centrifuged 4min, abandon supernatant;
(4) thallus is resuspended in 1mL EZ2, and every 50 μ L packing, one pipe is spare.
Note: the competent cell prepared can be converted directly or slow cooling freeze to -80 DEG C (4 DEG C, 1h;- 20 DEG C,
1h;-80℃).
Two, function complementation experiment
(1) 0.2-1 μ g (≤5 μ L) pESC-his-Twse plasmid or pESC-his plasmid (as control) is taken to be separately added into
Into 50 μ L erg1 competent cells;
(2) 500 μ L EZ3 solution are added, thoroughly mix;
(3) 30 DEG C of incubation 45min, rock 2-3 times in the process;
(4) 200 μ L of bacterium solution is taken to be coated on screening and culturing medium SC-his+ ergosterol (20ug/mL) solid medium, point
48~72h is not cultivated under 30 DEG C aerobic and oxygen free condition.
Experimental result is shown: (see the left side Fig. 6 1) under oxygen free condition, erg1 yeast defect bacterium can not add etembonate in SC-his
(a) is grown in alcohol culture medium, be transferred to the erg1 yeast defect bacterium of pESC-his empty carrier and is transferred to pESC-his-Twse carrier
Erg1 yeast defect bacterium can add in ergosterol culture medium in SC-his to be grown.Under conditions of aerobic (right side Fig. 6 2), only
There is the erg1 yeast defect bacterium for being transferred to pESC-his-Twse carrier that can be transferred to unloaded and not be transferred to carrier in middle growth
Erg1 defect saccharomycete can not all be grown.The results show: tripterygium wilfordii Twse gene has biological function.
Sequence table
<110>Capital University of Medical Sciences
<120>a kind of ERG1 gene defect Yeast engineering bacteria, its construction method and its utilization
<141> 2018-08-08
<160> 21
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1771
<212> DNA
<213>artificial sequence ()
<400> 1
ttcggtagag acaggggagc gagagagact gttattgtgt tccttgcttc tatctggatt 60
tgcatttcga aatggtggat cactgtttgc tcggctggat cctggcctcg gtgctcgggt 120
tcttcacttt gtattttttg gtgttgaagc ggacggatga cgagaagaga gcggttttgg 180
aggcgagaag agagggcatg gagagtctca acacgacaaa cggagaatgt agatctagtg 240
acggcgaaga cgtcgacgtc atcattgtag gagctggcgt cgccggagcc gctcttgctc 300
acactctcgg caaggatgga cgtagagtac gtgtaattga aagagacttg acagagcctg 360
accgcatagt tggtgaattg ctacaaccag ggggctacct caaattgatt gagttgggac 420
ttgaagattg tgttgaagaa attgatgctc aacgagtgtt tggctatgcc ttgtttaagg 480
atgggaaaaa tactcgactt tcttatccct tggaaaagtt tcattcagac gtctcaggga 540
gaagttttca caatggacgt ttcatacaga ggatgcgaca gaaatctgca tcgcttccaa 600
atgtacgatt ggagcaagga actgttactt ctctgctaga agcagatggg ataattaggg 660
gtgtgcagta caaaactaaa agtggggaag aacttaaagc atatgcttct ctgaccattg 720
tgtgtgatgg ctgtttctca aacttgcgac gctccctctg caaaccaaag gttgatgtac 780
cttcttgttt tgttggtttg attctcgaga attgcaacct tccacatgca aatcatggac 840
atgttatcct tggagatcct tcccctattt tgtgttatcc tatcagtagt actgaggttc 900
gctgtctagt tgatgtacct ggtcagaagg ttccctcaat ctcaaacggc gaaatggcaa 960
agtatttgaa gaccatggtg gctccacagc ttcctcctga agtccacgat tcctttgtgg 1020
ctgctgttga taagggaaac cttagaacaa tgccaaaccg aagcatgcca gcttctccct 1080
atcatactcc tggagctttg ttgatggggg atgcattcaa catgcgccac cctctaacag 1140
ggggaggaat gactgtggca ctcgctgata ttgtcgtgct gcggaatctt ctgagacctt 1200
tgcatgactt gaatgacgca cctacccttt gcaaatatct tgaatctttc tacacactgc 1260
gtaagcccgt ggcatccaca atcaacacac tggcaggtgc tttatacaag gtgttttgtg 1320
cctcacctga tcaagcaaga aaggaaatgc gtgaggcttg ctttgattat ttgagtcttg 1380
gaggggtttt cgctgcagga cctgtctctt tgctgtcggg tttaaaccca cgccccttaa 1440
gtttagtttg ccacttcttt gctgttgctg tattcggtgt tggacgttta ttattgccat 1500
tcccttcacc taaacgaatc tggatcggag ctagagtgat cacgagtgca tcaggaatca 1560
tcttccccat cattaaggct gaaggagtaa ggcaaatgtt ctttccggca acggttccag 1620
catactatcg agctcctccc accaagtgag atccaagtat taaggcaact gttaatccta 1680
gtccctagtt attatcatct acgttcccac ccttaaagtg aagggcaagg ttgaatgttt 1740
catcaaaaag ggtgtccctt accgcatcta a 1771
<210> 2
<211> 525
<212> PRT
<213>artificial sequence ()
<400> 2
Met Val Asp His Cys Leu Leu Gly Trp Ile Leu Ala Ser Val Leu Gly
1 5 10 15
Phe Phe Thr Leu Tyr Phe Leu Val Leu Lys Arg Thr Asp Asp Glu Lys
20 25 30
Arg Ala Val Leu Glu Ala Arg Arg Glu Gly Met Glu Ser Leu Asn Thr
35 40 45
Thr Asn Gly Glu Cys Arg Ser Ser Asp Gly Glu Asp Val Asp Val Ile
50 55 60
Ile Val Gly Ala Gly Val Ala Gly Ala Ala Leu Ala His Thr Leu Gly
65 70 75 80
Lys Asp Gly Arg Arg Val Arg Val Ile Glu Arg Asp Leu Thr Glu Pro
85 90 95
Asp Arg Ile Val Gly Glu Leu Leu Gln Pro Gly Gly Tyr Leu Lys Leu
100 105 110
Ile Glu Leu Gly Leu Glu Asp Cys Val Glu Glu Ile Asp Ala Gln Arg
115 120 125
Val Phe Gly Tyr Ala Leu Phe Lys Asp Gly Lys Asn Thr Arg Leu Ser
130 135 140
Tyr Pro Leu Glu Lys Phe His Ser Asp Val Ser Gly Arg Ser Phe His
145 150 155 160
Asn Gly Arg Phe Ile Gln Arg Met Arg Gln Lys Ser Ala Ser Leu Pro
165 170 175
Asn Val Arg Leu Glu Gln Gly Thr Val Thr Ser Leu Leu Glu Ala Asp
180 185 190
Gly Ile Ile Arg Gly Val Gln Tyr Lys Thr Lys Ser Gly Glu Glu Leu
195 200 205
Lys Ala Tyr Ala Ser Leu Thr Ile Val Cys Asp Gly Cys Phe Ser Asn
210 215 220
Leu Arg Arg Ser Leu Cys Lys Pro Lys Val Asp Val Pro Ser Cys Phe
225 230 235 240
Val Gly Leu Ile Leu Glu Asn Cys Asn Leu Pro His Ala Asn His Gly
245 250 255
His Val Ile Leu Gly Asp Pro Ser Pro Ile Leu Cys Tyr Pro Ile Ser
260 265 270
Ser Thr Glu Val Arg Cys Leu Val Asp Val Pro Gly Gln Lys Val Pro
275 280 285
Ser Ile Ser Asn Gly Glu Met Ala Lys Tyr Leu Lys Thr Met Val Ala
290 295 300
Pro Gln Leu Pro Pro Glu Val His Asp Ser Phe Val Ala Ala Val Asp
305 310 315 320
Lys Gly Asn Leu Arg Thr Met Pro Asn Arg Ser Met Pro Ala Ser Pro
325 330 335
Tyr His Thr Pro Gly Ala Leu Leu Met Gly Asp Ala Phe Asn Met Arg
340 345 350
His Pro Leu Thr Gly Gly Gly Met Thr Val Ala Leu Ala Asp Ile Val
355 360 365
Val Leu Arg Asn Leu Leu Arg Pro Leu His Asp Leu Asn Asp Ala Pro
370 375 380
Thr Leu Cys Lys Tyr Leu Glu Ser Phe Tyr Thr Leu Arg Lys Pro Val
385 390 395 400
Ala Ser Thr Ile Asn Thr Leu Ala Gly Ala Leu Tyr Lys Val Phe Cys
405 410 415
Ala Ser Pro Asp Gln Ala Arg Lys Glu Met Arg Glu Ala Cys Phe Asp
420 425 430
Tyr Leu Ser Leu Gly Gly Val Phe Ala Ala Gly Pro Val Ser Leu Leu
435 440 445
Ser Gly Leu Asn Pro Arg Pro Leu Ser Leu Val Cys His Phe Phe Ala
450 455 460
Val Ala Val Phe Gly Val Gly Arg Leu Leu Leu Pro Phe Pro Ser Pro
465 470 475 480
Lys Arg Ile Trp Ile Gly Ala Arg Val Ile Thr Ser Ala Ser Gly Ile
485 490 495
Ile Phe Pro Ile Ile Lys Ala Glu Gly Val Arg Gln Met Phe Phe Pro
500 505 510
Ala Thr Val Pro Ala Tyr Tyr Arg Ala Pro Pro Thr Lys
515 520 525
<210> 3
<211> 20
<212> DNA
<213>artificial sequence ()
<400> 3
tatcttttca cgtttcagaa 20
<210> 4
<211> 35
<212> DNA
<213>artificial sequence ()
<400> 4
tatcttttca cgtttcagaa gttttagagc tagaa 35
<210> 5
<211> 27
<212> DNA
<213>artificial sequence ()
<400> 5
gatcatttat ctttcactgc ggagaag 27
<210> 6
<211> 38
<212> DNA
<213>artificial sequence ()
<400> 6
atagcttgtc accttacgta caatcttgat ccggagct 38
<210> 7
<211> 35
<212> DNA
<213>artificial sequence ()
<400> 7
cttaggggca gacatactcc aagctgcctt tgtgt 35
<210> 8
<211> 35
<212> DNA
<213>artificial sequence ()
<400> 8
aaggcagctt ggagtatgtc tgcccctaag aagat 35
<210> 9
<211> 41
<212> DNA
<213>artificial sequence ()
<400> 9
tactactcag taataactta agcaaggatt ttcttaactt c 41
<210> 10
<211> 39
<212> DNA
<213>artificial sequence ()
<400> 10
agaaaatcct tgcttaagtt attactgagt agtatttat 39
<210> 11
<211> 35
<212> DNA
<213>artificial sequence ()
<400> 11
agggtgatgg ttcacgtagt gggccatcgc cctga 35
<210> 12
<211> 23
<212> DNA
<213>artificial sequence ()
<400> 12
gcaccataaa cgacattact ata 23
<210> 13
<211> 21
<212> DNA
<213>artificial sequence ()
<400> 13
accccaaaaa acttgattag g 21
<210> 14
<211> 120
<212> DNA
<213>artificial sequence ()
<400> 14
caggttattt cgaacaattg aaaaaaaaaa atcacagaaa aacatatcga gaaaagggtc 60
ctacagctta taagggagag aggataggaa ccgtcaaaca ttaagctgca cctttttttt 120
<210> 15
<211> 120
<212> DNA
<213>artificial sequence ()
<400> 15
aaaaaaaagg tgcagcttaa tgtttgacgg ttcctatcct ctctccctta taagctgtag 60
gacccttttc tcgatatgtt tttctgtgat tttttttttt caattgttcg aaataacctg 120
<210> 16
<211> 21
<212> DNA
<213>artificial sequence ()
<400> 16
cattacgcct atctaatctc c 21
<210> 17
<211> 19
<212> DNA
<213>artificial sequence ()
<400> 17
ttgacggttc ctatcctct 19
<210> 18
<211> 19
<212> DNA
<213>artificial sequence ()
<400> 18
ttcggtagag acaggggag 19
<210> 19
<211> 19
<212> DNA
<213>artificial sequence ()
<400> 19
ttagatgcgg taagggaca 19
<210> 20
<211> 37
<212> DNA
<213>artificial sequence ()
<400> 20
aaccctcact aaagggcatg gtggatcact gtttgct 37
<210> 21
<211> 37
<212> DNA
<213>artificial sequence ()
<400> 21
ctggcgaaga attgttaatt cacttggtgg gaggagc 37
Claims (1)
1. a kind of tripterygium wilfordii squalene epoxidase enzymes gene function verification method, comprising: tripterygium wilfordii squalene epoxidase will be contained respectively
The expression vector pESC-his-Twse of the enzyme gene and corresponding empty carrier pESC-his for being free of tripterygium wilfordii squalene epoxidase enzymes gene
It is transferred in ERG1 gene defection type yeast engineering bacterium competence cell, gained competent cell is then coated on " SC-his+
It on ergosterol " solid medium, is cultivated respectively under aerobic and oxygen free condition, if being transferred under aerobic and anaerobic containing tripterygium wilfordii
The ERG1 yeast defect bacterium of squalene epoxidase enzymes expression vector can grow, and confirm squalene epoxidase enzymes gene in tripterygium wilfordii
With biological function, wherein the ERG1 gene defection type yeast engineering bacterium competence cell is to have knocked out ERG1 gene completely
Yeast engineering bacterium competence cell, the tripterygium wilfordii squalene epoxidase enzymes gene order is as shown in SEQ ID NO:1, the ferment
Mother is BY4741 saccharomyces cerevisiae, and the knockout of the gene of the ERG1 defective yeast engineering bacteria is using the side CRISP/Cas9
Method knocks out, comprising:
(1) site gRNA of yeast ERG1 gene, the gene order in the site gRNA are screened are as follows:
TATCTTTTCACGTTTCAGAA;
(2) building knocks out the expression vector of yeast ERG1 gene:
Using EGR1-F and EGR1-R as primer, is cloned using p426-SNR52p-gRNA carrier for expression of eukaryon as template and linearly carried
Body, and blunt end cloning is carried out with T4 ligase, building obtains knocking out the gRNA expression vector of yeast ERG1 gene,
The primer sequence are as follows:
ERG1-F:TATCTTTTCACGTTTCAGAAGTTTTAGAGCTAGAA,
ERG1-R:GATCATTTATCTTTCACTGCGGAGAAG;
(3) Cas9 carrier is transformed, the selection markers TRP of p414-TEF1p-Cas9-CYC1t is replaced with into LEU;
(4) double-stranded DNA of ERG1 gene is obtained:
Design knocks out the dsOligo of yeast ERG1 gene, is knocked out by homologous recombination repair to target gene, ERG1-
The sequence of Oligo-F and ERG1-Oligo-R are as follows:
ERG1-Oligo-F:
CAGGTTATTTCGAACAATTGAAAAAAAAAAATCACAGAAAAACATATCGAGAAAAGGGTCCTACAGCTTATA
AGGGAGAGAGGATAGGAACCGTCAAACATTAAGCTGCACCTTTTTTTT,
ERG1-Oligo-R:
AAAAAAAAGGTGCAGCTTAATGTTTGACGGTTCCTATCCTCTCTCCCTTATAAGCTGTAGGACCCTTTTCTC
GATATGTTTTTCTGTGATTTTTTTTTTTCAATTGTTCGAAATAACCTG,
The dsOligo of the yeast ERG1 gene by annealing ERG1-Oligo-F and ERG1-Oligo-R to form DNA double chain,
And recovery purifying obtains;
(5) according to Frozen-EZ Yeast Transformation IITMKit specification prepares competent yeast cells;
(6) by the Cas9 carrier being transformed in the gRNA expression vector for knocking out yeast ERG1 gene in step (2), step (3) with
And the yeast ERG1 double-stranded DNA synthesized in step (4) converts in the competent yeast cells into rapid (5), acquisition is mutated successfully
ERG1 gene defect saccharomycete.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810896549.1A CN109022299B (en) | 2018-08-08 | 2018-08-08 | A kind of ERG1 gene defect Yeast engineering bacteria, its construction method and its utilization |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810896549.1A CN109022299B (en) | 2018-08-08 | 2018-08-08 | A kind of ERG1 gene defect Yeast engineering bacteria, its construction method and its utilization |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109022299A CN109022299A (en) | 2018-12-18 |
CN109022299B true CN109022299B (en) | 2019-09-10 |
Family
ID=64649601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810896549.1A Active CN109022299B (en) | 2018-08-08 | 2018-08-08 | A kind of ERG1 gene defect Yeast engineering bacteria, its construction method and its utilization |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109022299B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114774503B (en) * | 2022-06-20 | 2022-10-14 | 中国中医科学院中药研究所 | Squalene epoxidase and coding gene and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108359615A (en) * | 2018-02-09 | 2018-08-03 | 首都医科大学 | A kind of Yeast engineering bacteria of high yield cryptomeridiol |
-
2018
- 2018-08-08 CN CN201810896549.1A patent/CN109022299B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108359615A (en) * | 2018-02-09 | 2018-08-03 | 首都医科大学 | A kind of Yeast engineering bacteria of high yield cryptomeridiol |
Non-Patent Citations (3)
Title |
---|
Building Terpene Production Platforms in Yeast;Xun Zhuang等;《Biotechnology and Bioengineering》;20150930;第112卷(第9期);1854-1864 |
ERGl, Encoding Squalene Epoxidase, is Located on the Right Arm of Chromosome VII of Saccharomyces cerevisiae;KARINA M. LANDL等;《YEAST》;19961231;第12卷;609-613 |
MultiplexmetabolicpathwayengineeringusingCRISPR/Cas9 in Saccharomyces cerevisiae;TadasJakočiūnas等;《Metabolic Engineering》;20150128;第28卷;213-222 |
Also Published As
Publication number | Publication date |
---|---|
CN109022299A (en) | 2018-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106318934B (en) | Gene complete sequence of carrot β (1,2) xylose transferase and plasmid construction of CRISPR/CAS9 for transfecting dicotyledonous plants | |
CN104560742B (en) | Agriculture bacillus mediated ustilago esculenta transformant bacterial strain and its preparation method and application | |
CN108866093A (en) | A method of using CRISPR/Cas9 system to alfalfa site-directed point mutation | |
CN108060092A (en) | A kind of recombinant bacterium and application thereof | |
CN106459985B (en) | A kind of Mycobacterium tuberculosis genes engineering bacteria is preparing the application in steroidal compounds | |
CN107287272A (en) | A kind of preparation method of Tauro ursodesoxy cholic acid | |
CN106086058A (en) | A kind of method reducing Cordyceps militaris (L.) Link. fruiting time and raising fruiting yield | |
CN111057654B (en) | Cas9 gene knockout vector applicable to morinda officinalis endophytic fungus A761 and construction method and application thereof | |
CN109022299B (en) | A kind of ERG1 gene defect Yeast engineering bacteria, its construction method and its utilization | |
CN109293757B (en) | Phyllostachys pubescens PeTCP10 protein with function of controlling blade curling and application thereof | |
CN112553238B (en) | CRISPR/Cas9 vector applicable to coniothyrium minitans FS482 as well as construction method and application thereof | |
Balabanova et al. | Development of host strains and vector system for an efficient genetic transformation of filamentous fungi | |
CN103146722B (en) | Gene sequence of I-type tonoplast pyrophosphatase from ammopiptanthus nanus and cloning method of gene sequence | |
CN104212787A (en) | Panax japonicas beta-amyrin synthase gene and application thereof | |
CN102533574A (en) | Yellow wine yeast engineering strain with low urea yield and construction method thereof | |
CN116218799A (en) | CYP450 enzyme protein for catalyzing beta-amyrin 16 alpha hydroxylation, coding gene and application thereof | |
CN107723300B (en) | Overexpression of CgGsh1 gene to improve 2-phenethyl alcohol tolerance and yield of glycerol-producing candida | |
CN109694892A (en) | Prepare the method and kit of rhodioside | |
CN104293758B (en) | A kind of Panax Japonicus Var. Major β armomadendrins synthase gene and its application | |
CN106520766A (en) | Seaweed endogenesis constructive promoter and application thereof | |
CN113956990A (en) | Recombinant saccharomyces cerevisiae for producing dihydronilotinib as well as preparation method and application thereof | |
CN107903227B (en) | Succinic anhydride compound, gene and protein related to succinic anhydride compound and preparation method of succinic anhydride compound | |
CN114958637B (en) | Engineering bacterium for producing beta-eucalyptol as well as construction method and application thereof | |
CN114438109B (en) | Osmanthus gene OfTPS13.2 and application thereof | |
CN113430194B (en) | White birch gene editing method based on CRISPR/Cas9 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |